Cargando…

Nuclear GSK-3β and Oncogenic KRas Lead to the Retention of Pancreatic Ductal Progenitor Cells Phenotypically Similar to Those Seen in IPMN

Glycogen synthase kinase-3β (GSK-3β) is a downstream target of oncogenic KRas and can accumulate in the nucleus in pancreatic ductal adenocarcinoma (PDA). To determine the interplay between oncogenic KRas and nuclear GSK-3β in PDA development, we generated Lox-STOP-Lox (LSL) nuclear-targeted GSK-3β...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Li, Roeck, Kaely, Zhang, Cheng, Zidek, Brooke, Rodman, Esther, Hernandez-Barco, Yasmin, Zhang, Jin-San, Bamlet, William, Oberg, Ann, Zhang, Lizhi, Bardeesy, Nabeel, Li, Hu, Billadeau, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136019/ https://www.ncbi.nlm.nih.gov/pubmed/35646902 http://dx.doi.org/10.3389/fcell.2022.853003

Ejemplares similares

Oncogenic Kras-Mediated Cytokine CCL15 Regulates Pancreatic Cancer Cell Migration and Invasion through ROS
por: Messex, Justin K., et al.
Publicado: (2022)

State-of-the-art surgical treatment of IPMNs
por: Salvia, Roberto, et al.
Publicado: (2021)

Evaluating IPMN and pancreatic carcinoma utilizing quantitative histopathology
por: Glazer, Evan S., et al.
Publicado: (2016)

IPMN-LEARN: A linear support vector machine learning model for predicting low-grade intraductal papillary mucinous neoplasms
por: Hernandez-Barco, Yasmin Genevieve, et al.
Publicado: (2023)

Quantitative imaging to evaluate malignant potential of IPMNs
por: Hanania, Alexander N., et al.
Publicado: (2016)

Pancreatico-gastric fistula arising from IPMN associated with ductal adenocarcinoma of the pancreas: a case report and a literature review
por: AbuDalu, M., et al.
Publicado: (2023)

Imaging of IPMN of the pancreas: evaluation of malignant potential and resectability
por: Lee, Jeong Min
Publicado: (2015)

Humoral Predictors of Malignancy in IPMN: A Review of the Literature
por: Nista, Enrico C., et al.
Publicado: (2021)

KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
por: Zhang, Zining, et al.
Publicado: (2023)

Reappraisal of the Immunophenotype of Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs)—Gastric Pyloric and Small Intestinal Immunophenotype Expression in Gastric and Intestinal Type IPMNs—
por: Kobayashi, Mikiko, et al.
Publicado: (2014)

SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN
por: Zhang, Chuan-long, et al.
Publicado: (2023)

Targeted Nanoparticles for Imaging Incipient Pancreatic Ductal Adenocarcinoma
por: Kelly, Kimberly A, et al.
Publicado: (2008)

Precursor Lesions for Sporadic Pancreatic Cancer: PanIN, IPMN, and MCN
por: Distler, M., et al.
Publicado: (2014)

Characterization and management of cystic pancreatic neoplasms communicating lesions (IPMN)
por: Morana, Giovanni, et al.
Publicado: (2014)

Invasive carcinoma derived from branch duct-type IPMN may be a more aggressive neoplasm than that derived from main duct-type IPMN
por: OKABAYASHI, TAKEHIRO, et al.
Publicado: (2013)

Extent of Surgery and Implications of Transection Margin Status after Resection of IPMNs
por: Paini, Marina, et al.
Publicado: (2014)

Do molecular tests really differentiate malignant IPMNS from benign?
por: Basar, Omer, et al.
Publicado: (2016)

RNF43 Mutations in IPMN Cases: A Potential Prognostic Factor
por: Chang, Xiao Yan, et al.
Publicado: (2020)

KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
por: Yu, Shuang-Ni, et al.
Publicado: (2016)

Approaches to analyse dynamic microbial communities such as those seen in cystic fibrosis lung
por: Doud, Melissa, et al.
Publicado: (2009)

KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
por: Gurreri, Enrico, et al.
Publicado: (2023)

Spontaneous gastro-pancreatic fistula – a hitherto unknown natural history of IPMN?
por: Rao, V, et al.
Publicado: (2012)

The Clinical and Socio-Economic Relevance of Increased IPMN Detection Rates and Management Choices
por: Budde, Christoph, et al.
Publicado: (2015)

Limitations and prospects in the management of IPMN: a retrospective, single-center observational study
por: Peisl, Sarah, et al.
Publicado: (2023)

Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)
por: Zhang, Chaoyang, et al.
Publicado: (2023)

Synergy of GSK-J4 With Doxorubicin in KRAS-Mutant Anaplastic Thyroid Cancer
por: Lin, Bo, et al.
Publicado: (2020)

Synovial Inflammation in Patients with Hallux Valgus is Similar to Changes Seen in Those with Hallux Rigidus
por: Karzon, Anthony L., et al.
Publicado: (2022)

Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype
por: Fu, Yong, et al.
Publicado: (2015)

Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
por: Liu, Yu-Huei, et al.
Publicado: (2022)

Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2023)

Notch1 Is Not Required for Acinar-to-Ductal Metaplasia in a Model of Kras-Induced Pancreatic Ductal Adenocarcinoma
por: Avila, Jacqueline L., et al.
Publicado: (2012)

Intraductal papillary mucinous neoplasm of the pancreas (IPMN): clinico-pathological correlations and surgical indications
por: Baiocchi, Gian Luca, et al.
Publicado: (2010)

Extensive multifocal branch duct IPMN of the pancreas after liver transplantation: is surgery justified?
por: Branchi, Vittorio, et al.
Publicado: (2015)

Total Pancreatectomy for Malignant Intraductal Papillary Mucinous Neoplasm (IPMN) Complicated by Gastropancreatic Fistulae
por: Basnayake, Oshan, et al.
Publicado: (2020)

A greater incidence of nausea/vomiting reactions to Multihance(®) is seen among those of African descent
por: Kissinger, Kraig V, et al.
Publicado: (2015)

Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: Recent advancements provide hope (Review)
por: Zhang, Joshua, et al.
Publicado: (2023)

BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation
por: Hennig, R, et al.
Publicado: (2008)

Erratum to: Extensive multifocal branch duct IPMN of the pancreas after liver transplantation: is surgery justified?
por: Branchi, Vittorio, et al.
Publicado: (2015)

Prognostic influence of endoscopic ultrasound-guided fine needle aspiration in IPMN-derived invasive adenocarcinoma
por: Suzuki, Rei, et al.
Publicado: (2018)

Association of Chronic Pancreatitis and Malignant Main Duct IPMN: A Rare but Difficult Clinical Problem
por: Berger, Zoltán, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gmdla66up5it0k2etv7uhq540q